An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Smith, Jeffrey Michael ^a   Lowe, Richard F ^b   Fullerton, Judith ^c   Currie, Sheena M ^a   Harris, Laura ^d   Felker Kantor, Erica ^e  

^a JHPIEGO   (United States)

^b Venture Strategies Innovations   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Eclampsia; Magnesium sulfate; Pre eclampsia; Side effect

Indexed keywords

DIAZEPAM; GLUCONATE CALCIUM; MAGNESIUM SULFATE;

ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; EARLY DIAGNOSIS; ECLAMPSIA; HEART DISEASE; HUMAN; LOWEST INCOME GROUP; MATERNAL MORTALITY; OLIGURIA; PREECLAMPSIA; REFLEX; RESPIRATION DEPRESSION; TREATMENT OUTCOME;

ANTICONVULSANTS; ECLAMPSIA; FEMALE; HUMANS; MAGNESIUM SULFATE; MATERNAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; SEIZURES;

EID: 84873263813     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-34     Document Type: Article

References (60)

1. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Sem Perinatol 2012, 36:56-59.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-44.
3. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Carribbean. Br J Obstet Gynaecol 2005, 99:547-533.
4. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009, 33:130-137.
5. Garcia PVD. Maternal deaths due to eclampsia and HELLP syndrome. Int J Gynecol Obstet 2009, 104:90-94.
6. Khan KS, Wojdyla D, Say I, Gúlmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367(9516):1066-74.
7. World Health Organization WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia 2011, Geneva, http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf, World Health Organization.
8. Eclampsia Trial Collaborative Group Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995, 345:1455-63. Eclampsia Trial Collaborative Group.
9. Altman D, Carroli G, Duley B, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised, placebo-controlled trial. Lancet 2002, 359(9321):1877-90.
10. Duley L, Almeric M, Hall D. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev 2010, (8). Art. No.:CD007388.
11. Euser A, Cipolla M. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 2009, 40:1169-1175.
12. Pritchard JA. The use of the magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet 1955, 100:131-140.
13. Hunter L, Givvins K. Magnesium sulfate: past, present, and future. J Midwif Womens Health 2011, 56:566-573.
14. World Health Organization Managing Complications in Pregnancy and Childbirth: A Guide for Midwives and Doctors 2011, Geneva, http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9241545879/en/index.html, World Health Organization.
15. Barua A, Mundle S, Bracken H, Easterline T, Winikoff B. Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals. Int J Gynecol Obstet 2011, 115(3):231-234.
16. Firoz T, Sanghvi H, Merialdi M, von Dadelszen P. Pre-eclampsia in low and middle income countries. Best Pract ResClin Obstet Gynaecol 2011, 25:537-548.
17. Travares de Souza M, Dias Da Silva M, de Carvalho R. Integrative review: what is it? how to do it?. Einstein 2010, 8(1 Part 1):102-106.
18. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs 2005, 52(5):546-553.
19. World Bank How We Classify Countries 2011, http://data.worldbank.org/about/country-classifications, World Bank.
20. Alauddin M, Sarkar MK, Munshi S, Tapan N, Maitrayee SM. Efficacy and safety of magnesium sulphate (MgSO4) in the treatment of eclampsia. J Indian Med Assoc 2011, 109(7):485-6. 488.
21. Bhattacharjee N, Saha SP, Ganguly RP, Patra KK, Dhali B, Das N, Barui G. A randomized comparative study between low-dose intravenous magnesium sulphate and standard intramuscular regimen for treatment of eclampsia. J Obstet Gynaecol 2011, 31(4):298-303.
22. Bhattacharya S, Naskar A, Mondal S, Samana A, Pada P, 4 Should magnesium sulfate prophylaxis be used in all cases of severe preeclampsia?. Online J Health Allied Scs 2010, 9:12. 1-3, 4.
23. Bhalla AK, Dhali GJ, Dhali K. A safer and more effective treatment regimen for eclampsia. Am NZ J Obstet Gynaecol 1994, 34(2):144.
24. Chowdhury JR, Chaudhuri S, Bhattacharyya N, Biswas P, Panpalia M. Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate for treatment of eclampsia. J Obstet Gynaecol Res 2009, 35(1):119-125.
25. Chissel S, Botha J, Moodley J, McGadyen L. Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia. SAMJ 1994, 84(9):607-610.
26. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynecol 1990, 97:110-117.
27. Ekele BA, Badung SLH. Is serum magnesium estimate necessary in patients with eclampsia on magnesium sulphate?. Af J Reprod Health 2005, 9(1):128-132.
28. Malapaka SV, Ballal PK. Lose-dose magnesium sulfate versus Pritchard regimen for the treatment of eclampsia and imminent eclampsia. Int J Gynaecol Obstet 2011, 115(1):70-2.
29. Mahajan N, Thomas A, Soni R, Gaikwad N, Jain S. " Padhar regime" - a low-dose magnesium sulphate treatment for eclampsia. Gynecol Obstet Invest 2009, 67:20-24.
30. Manorot M, Tongsong T, Khettglang R. A comparison of serum magnesium sulfate levels in pregnant women with severe preeclampsia between intravenous and intramuscular magnesium sulfate regimens: A randomized controlled trial. J Med Assoc Thailand 1996, 79(2):76-82.
31. Mundle S, Regi A, Easterling T, Biswas B, Bracken H, Khedekar V, Shekhavat DR, Durocher J, Winikoff B. Treatment approaches for preeclampsia in low-resource settings: A randomized trial of the Springfusor pump for delivery of magnesium sulfate. Int J Womens Cardiovascular Health Preg Hyperten 2012, 2(1):32-38.
32. Shohaib T, Khan S, Javed I, Bhutta S. Loading dose of magnesium sulfate versus standard regime for prophylaxis of pre-eclampsia. J Coll Physicians Surg Pak 2009, 19(1):30-33.
33. Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol 1966, 9:954-972.
34. Aali B, Khazaeli P, Ghasemi F. Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy. J Obstet Gynaecol Res 2007, 3(2):138-143.
35. Belfort M, Anthony J, Saade G, Allen J. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003, 348:304-11.
36. Coetzee EJ, Dommissee J, Anthony J. A randomized controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998, 105:300-303.
37. Dayicioglu V, Sahinoglu Z, Kol E, Kucukbas M. The use of standard dose of magnesium sulfate in prophylaxis of eclamptic seizures: Do body mass index alterations have any effect on success?. Hypertens Pregnancy 2003, 22(3):257-265.
38. Deshmukh MM, Rajwade AA, Walke DD, Kutty VV, Kudtarkar RR. Preliminary report on the use of magnesium sulfate in cases of severe pre-eclampsia and eclampsia. J Postgrad Med 1985, 31:199-202.
39. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990, 97:104-109.
40. Phuapradit W, Saropala N, Haruvasin S, Thuvasethatkul P. Serum level of magnesium attained in magnesium sulfate therapy for severe preeclampsia. Asia Oceania J Obstet Gynaecol 1993, 19(4):387-390.
41. Begum R, Begum A, Johanson R, Ali MN, Akhter S. A low dose (" Dhaka" ) magnesium sulfate regime for eclampsia. Acta Obstet Gynecol Scand 2001, 80(11):998-1002.
42. Shilva, Saha SC, Kalra J, Prasad R. Safety and efficacy of low-dose MgSO4 in the treatment of eclampsia. Int J Gynaecol Obstet 2007, 97(2):150-151.
43. The Partnership for Maternal, Newborn & Child Health A Global Review of the Key Interventions Related to Reproductive, Maternal, Newborn and Child Health (RMNCH) 2011, Geneva, http://www.who.int/pmnch/topics/part_publications/essentialinterventions14_12_2011low.pdf, The Partnership for Maternal, Newborn & Child Health.
44. Hill S, Yang A, Bero L. Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One 2012, 7(5):e38055. [e-pub, 2012, May 31].
45. United Nations The UN Commission on Life-Saving Commodities for Women and Children, United Nations 2011 http://www.everywomaneverychild.org/resources/un-commission-on-life- saving-commodities/about, United Nations.
46. Author Magnesium Sulfate Side Effects 2012, http://www.drugs.com/sfx/magnesium-sulfate-side-effects.html, Author.
47. McDonald S, Lutsiv O, Dzaja N, Duley L. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. Int J Gynecol Obstet 2012, 118:90-96.
48. Lu J, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic priniciples. Clin Pharmacokinet 2000, 38(4):305-314.
49. Ciarkowski SL, Stalburg CM. Medication safety in obstetrics and gynecology. Clinical Obstet Gynecol 2010, 53(3):482-99.
50. Ridge A, Eero L, Hill S. Identifying barriers to the availability and use of magnesium sulfate injection in resource poor countries: a case study in Zambia. BMC Health Serv Res 2010, 10:340.
51. Sevene E, Lewin S, Mariano A, Woelk G, Exman AD, Matinhure S, Cliff J, Fernandes B, Danield K. System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ 2005, 331:765-769.
52. Aaserud M, Lewin S, Innvaer S, Paulsen E, Dahlgren A, Trommald M, Duley L, Zwarenstein M, Oxman A. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Services Res 2005, 5:68.
53. Norwitz E, Bahtiyar M, Sibai B. Can postgraduate courses in maternal-fetal medicine change clinical attitude?. J Mater Fetal Neonatal Med 2005, 19(5):311-317.
54. Muganyizi P, Shagdara M. Predictors of extra care among magnesium sulphate treated eclamptic patients at Muhimbili National Hospital, Tanzania. BMC Pregnancy Childbirth 2011, 11:41. http://www.biomedcentral.com/1471-2393/11/41.
55. Adewole IF, Oladokun A, Okewole AI, Omigbodun AO, Afolabi A, Ekele B, Audu LR, Obed Y. Magnesium sulphate for treatment of eclampsia: the Nigerian experience. Afr J Med Med Sci 2000, 29(3-4):239-41.
56. Tita A, Selwyn B, Waller DK, Kapadia A, Dongmo S. Evidence-based reproductive health care in Cameroon: population-based study of awareness, use and barriers. Bull World Health Organ 2005, 83:895-903.
57. Tukur J. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia. Ann Afr Med 2009, 8(2):76-80.
58. Nisell H, Palm K, Wolff K. Prediction of matenral and fetal complications in preeclampsia. Acta Obstet Gynecol Scand 2000, 79:19-23.
59. Small M, Kershaw T, Frederic R, Blanc C, Neale D, Copel J, Williams K. Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti. J Matern Fetal Neonatal Med 2005, 18(5):343-348.
60. Omu AE, Al-Harmi J, Vedi HL, Miechkova L, Sayed AF, Al-Ragum NS. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait. Med Princ Pract 2008, 17(3):227-232.